Hugemed has raised $22.0M in total across 1 funding round.
Hugemed's investors include Qiming Venture Partners, RTW Investments.
HugeMed is a technology company specializing in medical equipment, particularly in the development, manufacturing, and sales of advanced endoscopic devices. Their product portfolio includes single-use and reusable endoscopes, video laryngoscopes, and staplers designed for clinical surgery, emergency care, anesthesia, respiratory treatment, pediatrics, ICU, and operating rooms. HugeMed serves hospitals and medical institutions worldwide, addressing the need for high-quality, reliable, and innovative endoscopic solutions that improve surgical precision and patient outcomes. The company has demonstrated strong growth momentum, exporting to over 100 countries and supplying more than 10,000 medical institutions globally, supported by a production capacity exceeding 50,000 units monthly[1][2][4][5].
Founded in 2014, HugeMed emerged as a high-tech medical equipment developer based in Shenzhen, China. The company was established with a focus on research and development, manufacturing, and after-sales service in the medical endoscope sector. The founding team built a comprehensive operation covering R&D, production, sales, and service, enabling rapid innovation and market penetration. Early traction was marked by the successful launch of single-use ureterorenoscopes and other endoscopic devices, which gained widespread adoption due to their ease of use and advanced features, such as the “No-Touch” ureter engagement technique praised by medical professionals[1][2].
HugeMed rides the global trend toward minimally invasive surgery and the increasing demand for disposable medical devices that reduce infection risk and improve patient safety. The timing aligns with growing healthcare infrastructure investments worldwide and heightened awareness of hygiene standards post-pandemic. Market forces such as rising chronic disease prevalence and aging populations further drive demand for advanced endoscopic technologies. HugeMed influences the broader ecosystem by providing scalable, innovative solutions that enable hospitals to adopt safer, more efficient surgical practices, contributing to improved healthcare outcomes globally[1][2][4].
Looking ahead, HugeMed is positioned to expand its product portfolio and deepen its penetration in emerging and developed markets by leveraging its strong manufacturing capacity and global distribution network. Trends shaping its journey include increased adoption of single-use medical devices, digital integration in surgical tools, and growing demand for specialized endoscopic procedures. HugeMed’s influence is likely to grow as it continues to innovate and support healthcare providers with cutting-edge, reliable medical technologies, reinforcing its role as a key player in the medical device industry[2][3].
Hugemed has raised $22.0M across 1 funding round. Most recently, it raised $22.0M Series C in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2025 | $22.0M Series C | Qiming Venture Partners, RTW Investments |